Allgens Medical Technology Co. Ltd.

Allgens Medical Technology Co. Ltd.

688613.SS - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.11B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Allgens Medical Technology Co. Ltd.Allgens Medical Technology Co. Ltd.156.40.38%1%6.7-
$5.04

Current Fair Value

24.4% downside

Overvalued by 24.4% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.11 Billion
Enterprise Value$1.04 Billion
Annual dividend$0.03
Dividend yield0.38%
Earnings per Share$0.1
Beta0.6
Outstanding Shares134,360,900

Return

Return on Equity0.55%ROE
Return on Assets0.52%
Return on Invested Capital0.23%

Valuation & Multiples

P/E Ratio156.37P/E Ratio
PEG-193.95PEG
Price to Sales6.67Price to Sales
Price to Book Ratio0.67Price to Book Ratio
Enterprise Value to Revenue4.57
Enterprise Value to EBIT297.65
Enterprise Value to Net Income131
Total Debt to Enterprise0.03
Debt to Equity0.02Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 2, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
April 26, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Allgens Medical Technology Co. Ltd.

281 employees
CEO: Zhiye Qiu

Allgens Medical Technology Co. Ltd. operates as a medical device firm, concentrating on the development and production of sophisticated biomimetic synthetic bone graft systems. These innovative solutions are engineered for global deploym...